Stay updated on Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added Marinesco-Sjögren syndrome and the Genetic and Rare Diseases Information Center as related resources.
    Difference
    0.2%
    Check dated 2026-04-02T14:51:29.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T21:19:52.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    - The revision tag on the page updated from v3.4.2 to v3.4.3. No visible content changes are indicated.
    Difference
    0.1%
    Check dated 2026-03-11T18:09:46.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Administrative site updates: the page now lists Revision: v3.4.2 and the older funding-status notice and Revision: v3.4.1 have been removed; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:27:56.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page now includes a government funding notice about NIH operations and the revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:20:48.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The changes are cosmetic and metadata-related, including Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, which do not alter core study content, eligibility criteria, outcomes, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T20:31:48.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.